Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumit Gupta

Showing results (291-300 of 362) with videos related to

Pageof 37
Sort By:
Analytical Biochemistry|February 14, 2016
Development of a RapidFire mass spectrometry assay and a fluorescence assay for the discovery of kynurenine aminotransferase II inhibitors to treat central nervous system disordersHao Lu, Lisa Kopcho, Kaushik Ghosh, et al.
Cancer|October 27, 2020
The cost-effectiveness of treating childhood cancer in 4 centers across sub-Saharan AfricaJessie Githang'a, Biobele Brown, Inam Chitsike, et al.
BMJ Open|September 2, 2025
Feasibility and clinical and implementation effectiveness of an adapted early warning signs and symptoms intervention for the early detection of childhood cancer in Cameroon and Kenya: protocol for a quasi-experimental, hybrid type 2 implementation effectiveness studyHayle Noh, Melinda Piriyanca Chelva, Glenn Mbah Afungchwi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 25, 2023
Enhancing Composite Toughness Through Hierarchical Interphase FormationSumit Gupta, Tanvir Sohail, Marti Checa, et al.
The Lancet. Oncology|September 3, 2021
Transforming Canada's role in global cancer controlDanielle Rodin, Anna J Dare, Reanne Booker, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2021
Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, CanadaSumit Gupta, Rinku Sutradhar, Qing Li, et al.
Blood Advances|June 25, 2026
Minimal Residual Disease by High-Throughput Sequencing in Standard Risk-Favorable Pediatric B-Lymphoblastic LeukemiaCarol Fries, Lingyun Ji, Meenakshi Devidas, et al.
The Lancet. Child & Adolescent Health|September 1, 2018
Assessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry studyJoanne F Aitken, Danny R Youlden, Andrew S Moore, et al.
Pediatric Blood & Cancer|May 18, 2021
Phase-specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group-based treatment for childhood acute lymphoblastic leukemia: A population-based studyMylene Bassal, Mariana Silva, Serina Patel, et al.
Pediatric Blood & Cancer|May 15, 2026
Serological Benefit of SARS-CoV-2 Vaccination Relative to Infection in Children With Acute Lymphoblastic LeukemiaJanna R Shapiro, Freda Qi, Karen Colwill, et al.
Pageof 37

Showing results (291-300 of 362) with videos related to

Sort By:
Pageof 37
Analytical Biochemistry|February 14, 2016
Development of a RapidFire mass spectrometry assay and a fluorescence assay for the discovery of kynurenine aminotransferase II inhibitors to treat central nervous system disordersHao Lu, Lisa Kopcho, Kaushik Ghosh, et al.
Cancer|October 27, 2020
The cost-effectiveness of treating childhood cancer in 4 centers across sub-Saharan AfricaJessie Githang'a, Biobele Brown, Inam Chitsike, et al.
BMJ Open|September 2, 2025
Feasibility and clinical and implementation effectiveness of an adapted early warning signs and symptoms intervention for the early detection of childhood cancer in Cameroon and Kenya: protocol for a quasi-experimental, hybrid type 2 implementation effectiveness studyHayle Noh, Melinda Piriyanca Chelva, Glenn Mbah Afungchwi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 25, 2023
Enhancing Composite Toughness Through Hierarchical Interphase FormationSumit Gupta, Tanvir Sohail, Marti Checa, et al.
The Lancet. Oncology|September 3, 2021
Transforming Canada's role in global cancer controlDanielle Rodin, Anna J Dare, Reanne Booker, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2021
Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, CanadaSumit Gupta, Rinku Sutradhar, Qing Li, et al.
Blood Advances|June 25, 2026
Minimal Residual Disease by High-Throughput Sequencing in Standard Risk-Favorable Pediatric B-Lymphoblastic LeukemiaCarol Fries, Lingyun Ji, Meenakshi Devidas, et al.
The Lancet. Child & Adolescent Health|September 1, 2018
Assessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry studyJoanne F Aitken, Danny R Youlden, Andrew S Moore, et al.
Pediatric Blood & Cancer|May 18, 2021
Phase-specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group-based treatment for childhood acute lymphoblastic leukemia: A population-based studyMylene Bassal, Mariana Silva, Serina Patel, et al.
Pediatric Blood & Cancer|May 15, 2026
Serological Benefit of SARS-CoV-2 Vaccination Relative to Infection in Children With Acute Lymphoblastic LeukemiaJanna R Shapiro, Freda Qi, Karen Colwill, et al.
Pageof 37